Would that be the top pick of 2020 ? Exelixis shows strong balance sheet plus the growth potential from further expansion. Stock Mover - Exelixis Further Expands Prostate Cancer Cohort in Phase 1b - Exelixis to Present at the 38th Annual J.P. Morgan Healthcare Conference on January 14, 2020
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.